Finding and selecting specific antibodies quickly using advanced technology.
Rapid identification and selection of functional antigen-specific monoclonalantibodies by FcGR-enabled screening on CellRaft Arrays in the CellRaft AIRSystem
This study is looking at a new way to make better antibodies that help with diagnosing and treating illnesses, using a special technology to quickly find and select the best cells, so patients can get more effective treatments.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cell Microsystems, INC. NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10843286 on NIH RePORTER |
What this research studies
This research focuses on improving the production of monoclonal antibodies, which are crucial for various medical applications, including diagnostics and treatments. It utilizes a novel technology called CellRaft, which allows for the imaging and isolation of individual cells in a highly efficient manner. By automating the screening process, the research aims to enhance the speed and quality of antibody selection, ultimately leading to better therapeutic products. Patients may benefit from more effective treatments derived from these improved antibodies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who require monoclonal antibody therapies for their conditions.
Not a fit: Patients who do not require monoclonal antibody treatments or those with conditions not addressed by antibody therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective antibody-based treatments for various diseases.
How similar studies have performed: Other research has shown success with similar automated antibody screening technologies, indicating a promising approach.
Where this research is happening
Durham, United States
- Cell Microsystems, INC. — Durham, United States (Active)
Researchers
- Principal investigator: Hartman, Jessica — Cell Microsystems, INC.
- Study coordinator: Hartman, Jessica
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.